Wednesday, December 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Almonty Strengthens Leadership with Appointment of Former US Army General

Dieter Jaworski by Dieter Jaworski
December 2, 2025
in Commodities, Industrial, Mergers & Acquisitions, Penny Stocks
0
Almonty Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

In a strategic move to bolster its operational capabilities across multiple continents, tungsten producer Almonty Industries has appointed a retired US Army Brigadier General to a key executive role. Steven L. Allen, a decorated military leader, has joined the company as its new Chief Operating Officer.

A Strategic Hire for Global Operations

The appointment of Steven L. Allen brings 33 years of senior leadership experience from the United States Army to Almonty’s management team. His background includes command of the 19th Expeditionary Sustainment Command and service as the Director of Logistics for US Forces in Korea. This deep logistical and command experience is viewed as directly applicable to the company’s current phase of aggressive operational expansion.

Allen’s military honors underscore a career of high-level responsibility:
* Defense Superior Service Medal
* Legion of Merit
* Bronze Star Medal
* Combat Infantryman Badge
* Former Commander of the U.S. Army Ordnance School

CEO Lewis Black highlighted that Allen’s “extensive Korea experience” makes him uniquely qualified to optimize tungsten supply flows through the company’s global network, a critical need at this juncture.

Timing Coincides with Flagship Mine Commissioning

This leadership change comes at a pivotal moment for Almonty, as it advances the commissioning of its flagship Sangdong mine in South Korea. Historically one of the world’s largest and highest-grade tungsten deposits, Sangdong is projected to supply over 80% of global tungsten production outside of China once at full capacity.

Should investors sell immediately? Or is it worth buying Almonty?

The new COO’s mandate extends well beyond Sangdong, encompassing oversight of several key projects:
* Optimization of tungsten deliveries from the Sangdong mine in South Korea.
* Management of the Panasqueira mine in Portugal.
* Acceleration of the Sangdong molybdenum project.
* Advancement of the Gentung Browns Lake project in Montana, USA.

US Entry and Western Supply Chain Positioning

Allen’s appointment follows Almonty’s recent acquisition of the Gentung Browns Lake tungsten project in Montana. This deal marks the company’s first operational footprint in the United States, establishing it as an integrated Western tungsten supplier with assets in Europe, Asia, and North America.

Production at the Montana site is slated to commence in the second half of 2026. Preliminary plans target an annual output of approximately 140,000 metric tonne units of WO3. The project is located within a historic tungsten district that once supplied US strategic stockpiles.

Deepening Ties to Defense Sector Supply Chains

The recruitment of a highly decorated military logistics expert reinforces Almonty’s strategic positioning within defense industry supply chains. Tungsten remains a critical material for armor, ammunition, and electronics manufacturing. Recent US procurement bans and export restrictions from China have significantly heightened the strategic importance of non-Chinese tungsten sources.

The company currently holds a market capitalization of approximately $1.59 billion. In a recent development, Sphene Capital raised its price target for Almonty from 8.40 to 13.50 Canadian dollars, citing the expanded resource base resulting from the Gentung acquisition.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from December 3 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 3.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Ocugen Stock
Analysis

Ocugen’s Pivotal Moment: Can a Florida Presentation Reverse Its Fortunes?

December 3, 2025
Eli Lilly Stock
Analysis

Eli Lilly’s Strategic Gambit: A Price War for Market Supremacy

December 3, 2025
Red Cat Stock
Analysis

Leadership Shake-Up at Red Cat Amid Financial Shortfall

December 3, 2025
Next Post
Movado Stock

Movado Shares Surge: Is a Record High Within Reach?

Opendoor Stock

Opendoor Shares Signal Deep Distress as Losses Mount and Insiders Sell

Microsoft Stock

Microsoft's Strategic Push into the European Market Gains Momentum

Recommended

Rocket Lab USA Stock

Rocket Lab USA: A Study in Contrasting Financial Signals

3 months ago
Deere Stock

Deere’s Market Crossroads: Divergent Signals from Analysts and Investors

2 months ago
Amgen Stock

Amgen’s Strategic Crossroads: Innovation Meets Intensifying Competition

3 months ago
Eastman Chemical Stock

Eastman Chemical Leadership Bets Big with Major Stock Purchases

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Beyond Meat Shares: A Speculative Spike Meets Harsh Financial Reality

Eli Lilly’s Strategic Gambit: A Price War for Market Supremacy

Amazon’s Dual-Pronged Strategy to Reignite Growth

Alphabet’s Stock Surge: AI Ambitions Fuel Record Rally

Leadership Shake-Up at Red Cat Amid Financial Shortfall

Tesla’s Valuation Under Scrutiny Amid Conflicting Signals

Trending

Ocugen Stock
Analysis

Ocugen’s Pivotal Moment: Can a Florida Presentation Reverse Its Fortunes?

by Felix Baarz
December 3, 2025
0

Investors in Ocugen are facing a critical test of resolve. The biotech firm's shares have been under...

PayPal Stock

PayPal’s Dividend Debut Fails to Rally Investor Confidence

December 3, 2025
Marvell Technology Stock

Marvell Technology’s Strategic Surge: A Dual-Pronged Bet on AI Dominance

December 3, 2025
Beyond Meat Stock

Beyond Meat Shares: A Speculative Spike Meets Harsh Financial Reality

December 3, 2025
Eli Lilly Stock

Eli Lilly’s Strategic Gambit: A Price War for Market Supremacy

December 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ocugen’s Pivotal Moment: Can a Florida Presentation Reverse Its Fortunes?
  • PayPal’s Dividend Debut Fails to Rally Investor Confidence
  • Marvell Technology’s Strategic Surge: A Dual-Pronged Bet on AI Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com